Longevity Investors Lunch 2026

Longevity Investors announces the upcoming Longevity Investors Lunch 2026, an exclusive, application-only gathering designed specifically for investors seeking exposure to the most compelling opportunities emerging at the intersection of longevity science, technology, and capital. Held during the World Economic Forum in Davos, the event convenes a highly curated group of global investors alongside select longevity scientists, researchers, and industry leaders shaping the future of health and aging.

Since its launch in 2022, the Longevity Investors Lunch has established itself as a trusted platform – one that bridges capital allocators with frontier science, applied longevity technologies, and academically-driven innovation moving toward commercialization. The event is purpose-built to translate scientific progress into investable insight, enabling informed capital deployment.

LIL2026 1

Inside the Longevity Investors Lunch in Davos — curated discussions bringing together investors, scientists, and industry leaders in an intimate setting.

The 2026 program will feature expert-led panels, focused insights, and curated networking sessions designed to foster meaningful dialogue and long-term collaboration between investors and the scientific community. Discussions will focus on areas including translational longevity science, computational biology, precision medicine, AI-enabled healthcare, and scalable interventions targeting aging and age-related disease. All discussions are shaped through an investor lens rather than purely academic exploration.

Announced Speakers for LIL 2026

LIL2026 2

Prof. Evelyne Yehudit Bischof, MD, PhD, MPH

Director, Sheba Longevity Center

Internationally recognized physician-scientist advancing translational longevity medicine, clinical innovation, and evidence-based health optimization.

Jordan Shlain, MD

Founder & Chairman, Private Medical

Physician, entrepreneur, and healthcare innovator known for advancing prevention-first medical care and long-term health strategy.

Dr. Liv Kraemer, MD, PhD

Founder, Dr. Liv Kraemer Skin Longevity Clinic

Dermatologist and longevity researcher specializing in skin biology, preventive dermatology, and personalized aesthetic-health integration.

Peter Fedichev

CEO, GERO.ai

Computational biophysicist and AI pioneer focused on aging biomarkers, systemic resilience, and data-driven longevity therapeutics.

Dr. Andrea Gartenbach, MD

Longevity Physician, Axmann/Gartenbach

Internal medicine specialist and longevity expert focusing on cardiometabolic prevention, functional and hormone-based therapies, and personalized performance-driven health optimization.

Dr. Neven Pičuljan, PhD

Co-Founder, Aion Longevity

AI engineer and technology entrepreneur applying machine learning to integrate wearable data, lab results, and longitudinal wellbeing signals—advancing personalized, data-driven longevity analytics and precision health insights.

“We are proud to host the fifth edition of our Longevity Investors Lunch in January 2026 in Davos as a side-event during the World Economic Forum. Our vision and ambition is still the same: to bring more money into the emerging longevity industry by attracting investors in Davos who support research and startups in the industry.“ says Marc P. Bernegger, Co-Founder and Host of Longevity Investors.

“Longevity is developing at an extraordinary pace, yet many still wonder where the meaningful inflection points lie. LIL 2026 in Davos gives us the opportunity to filter out the noise, examine what the science really tells us, and connect investors with the innovators building solutions that can genuinely enhance healthspan.” says Dr. Tobias Reichmuth, Co-Founder and Host, Longevity Investors

LIL2026 3

Longevity Investors Co-Founders Marc P. Bernegger and Dr. Tobias Reichmuth, CEO Lucy Kupcova, and LIL 2025 speaker Dr. Deepak Chopra at the Longevity Investors Lunch in Davos.

LIL 2026 builds on a longstanding tradition of convening leaders who shape the future of healthspan, medicine, and scientific progress. As longevity science accelerates, the gathering offers an essential platform for investors and innovators to align on the breakthroughs, trends, and foundational work driving the next wave of global health transformation.

That dialogue continues with the seventh edition of the Longevity Investors Conference, taking place September 14–17, 2026, in Gstaad, Switzerland. Hosted in a private, invitation-only setting at a 5-star luxury hotel, the Longevity Investors Conference is the world’s most private investor conference dedicated to longevity, bringing together key opinion leaders, institutional and private investors, family offices, and funds to explore the scientific and investment foundations of human healthspan extension.

Together, the Longevity Investors Lunch and the Longevity Investors Conference reflect a shared conviction: as advances in biotechnology, medicine, and data-driven science accelerate, longevity is emerging as one of the defining investment opportunities of the decades ahead—and requires informed capital, rigorous dialogue, and long-term perspective.